CV
Education
- PhD in Biotechnology, Universitat de Barcelona (Spain), 2019
- Biohealth Computing Erasmus Mundus Master,Université Joseph Fourier (France), 2014
- Bachelor’s degree in Biochemistry, Universitat de Barcelona (Spain), 2013
Work Experience
Part-time fellow, Spanish Cancer Association (“Asociación Española Contra el Cáncer”), 2011-2012
Ph.D. fellow (scholarship from ‘La Caixa’ Foundation), Universitat de Barcelona (Spain), 2014-2018
Research Associate in the project ‘PT17/0009/00018 ISCIII- Platform of Bioinformatics of Carlos III Health Institute, metabolomics node’. Universitat de Barcelona (Spain), 2019-2020
Research Associate in the project “Countering the metabolic reprogramming associated with metastasis and resistance to treatment to prevent therapeutic failure in prostate and colon cancer”. Universitat de Barcelona (Spain), 2020-2021
Research Associate working in modelling, analysing and interpretation of genomic and multi-omic data. BHF Cardiovascular Epidemiology Unit. Department of Public Health and Primary Care. University of Cambridge (United Kingdom), 2021-
Awards
Dr Carles Foguet Coll:
Won a silver medal in the 2009 Spanish Chemistry Olympics.
Was awarded a fellowship from the Spanish Cancer Association (“Asociación Española Contra el Cáncer”) to work part-time in a research laboratory (“Programa de Prácticas de Laboratorio Durante el Curso Académico”) in 2011.
Won the Outstanding Graduation Award (“Premi Extraordinari de Grau”) for the highest cumulative grade point average among the Biochemistry graduates in the University of Barcelona class of 2013.
Was awarded an Erasmus Mundus Scholarship in 2014 to study the Biohealth Computing Master programme.
Was awarded a Ph.D. fellowship from ’La Caixa’ Foundation in 2015.
Participation In Research Projects
Analysis of the metabolic reprogramming underlying metastasis and identification of new therapeutic approaches against cancer (SAF2014-56059-R). 01/10/2014 to 31/12/2017. Financing administration: Ministry of Economy and Competitivity (Spain). Principal Investigator: Marta Cascante
Integrative Biochemistry Research Group (2017SGR1033). 01/01/2017 to 30/09/2021. Financing administration: University and Research Grants Management Agency (AGAUR; Spain). Principal Investigator: Marta Cascante
National Institute of Bioinformatics (PT17/0009/0018). 01/01/2018 to 1/12/2020. Financing administration: Ministry of Economy and Competitivity (Spain). Principal Investigator: Marta Cascante
PhenoMeNal: A comprehensive and standardised e-infrastructure for analysing medical metabolic phenotype data (EC654241). 01/09/2015 to 31/08/2018. Financing administration: European Commission. Principal Investigator: Christoph Steinbeck
Biomedical Research Network Center (CIBER). 01/01/2018 to present day. Financing administration: Ministry of Economy and Competitivity (Spain). Principal Investigator: Marta Cascante
Countering the metabolic reprogramming associated with metastasis and resistance to treatment to prevent therapeutic failure in prostate and colon cancer (SAF2017-89673-R). 01/01/2018 to 31/12/2020. Financing administration: Ministry of Economy and Competitivity (Spain). Principal Investigator: Marta Cascante
Identification of metabolic subtypes of colorectal cancer for the development of personalized medicine (PID2020-115051RB-I00). 01/09/2021 to present day. Financing administration: Ministry of Science and Innovation (Spain). Principal Investigator: Marta Cascante and Pedro Ramon de Atauri
HDRUK Multi-omics Consortium. 19/04/2021 to present day 19/10/2022. Financing administration: UK Research and Innovation. Principal Investigator: Adam Butterworth
Large-scale integrative genomic studies of high-dimensional traits in cardiovascular diseases (RG/18/13/33946). 19/04/2021 to 07/12/2023. Financing administration: British Heart Foundation. Principal Investigator: John Danesh
Large-scale integrative molecular studies of CVDs in multi-ethnic cohorts (RG/F/23/110103). 05/2024 to present day. Financing administration: British Heart Foundation. Principal Investigator: John Danesh
Talks
Genome-Scale Metabolic Modelling: From Cells to Biobanks. London Metabolomics Network Winter 2025 Meeting. 2025. London (United kingdom). Invited talk.
Foguet, C. Genetically personalised organ-specific metabolic models: A new tool to characterise how genetic variants condition metabolic phenotypes. Cambridge Cardiovascular/BHF CRE Annual symposium 2023. 2023. Cambridge(United kingdom). Invited talk.